Literature DB >> 25645011

The delay time in sickle cell disease after 40 years: A paradigm assessed.

Frank A Ferrone1.   

Abstract

Sickle hemoglobin polymerization commences with a striking latency period, called a "delay time" followed by abrupt polymer formation. The delay time is exceedingly concentration dependent. This discovery (40 years ago) led to the "kinetic hypothesis," that is, that the pathophysiology was related to the relationship between the delay time and the capillary transit. The delay time is well described by a double-nucleation mechanism of polymer formation. In macroscopic volumes, the delay time is highly reproducible, but in small volumes such as erythrocytes, under certain conditions, the intrinsic delay time can be augmented by a stochastic delay owing to random waiting times for the first nucleus to form. This lengthens the average delay and adds further protection from vaso-occlusion. When oxygen removal is not sudden, the growth of polymers after the delay time is limited by the rate of oxygen removal, further lengthening the time before occlusion may occur. This is important if some polymers have remained in the cell after pulmonary transit as their presence otherwise would obliterate any delay. The difficulty of deforming a cell once polymerized rationalizes the "two-step" model of vaso-occlusion in which a postcapillary adhesion event is followed by a sickling logjam. The delay time that is required is therefore generalized to be the delay time for an erythrocyte to move beyond regions in the venuoles where adherent cells have reduced the available lumen. The measurements of delay times correlate well with the severity of sickling syndromes. They also correlate with the improvements owing to the administration of hydroxyurea.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645011     DOI: 10.1002/ajh.23958

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  18 in total

1.  High-throughput assessment of hemoglobin polymer in single red blood cells from sickle cell patients under controlled oxygen tension.

Authors:  Giuseppe Di Caprio; Ethan Schonbrun; Bronner P Gonçalves; Jose M Valdez; David K Wood; John M Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 2.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

Review 3.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

4.  Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease.

Authors:  Quan Li; Eric R Henry; James Hofrichter; Jeffrey F Smith; Troy Cellmer; Emily B Dunkelberger; Belhu B Metaferia; Stacy Jones-Straehle; Sarah Boutom; Garrott W Christoph; Terri H Wakefield; Mary E Link; Dwayne Staton; Erica R Vass; Jeffery L Miller; Matthew M Hsieh; John F Tisdale; William A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

5.  Probing the Twisted Structure of Sickle Hemoglobin Fibers via Particle Simulations.

Authors:  Lu Lu; Xuejin Li; Peter G Vekilov; George Em Karniadakis
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

6.  Universality of supersaturation in protein-fiber formation.

Authors:  Troy Cellmer; Frank A Ferrone; William A Eaton
Journal:  Nat Struct Mol Biol       Date:  2016-03-28       Impact factor: 15.369

Review 7.  A microfluidic platform to study the effects of vascular architecture and oxygen gradients on sickle blood flow.

Authors:  Xinran Lu; Michelle M Galarneau; John M Higgins; David K Wood
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

8.  Deamidation of Human γS-Crystallin Increases Attractive Protein Interactions: Implications for Cataract.

Authors:  Ajay Pande; Natalya Mokhor; Jayanti Pande
Journal:  Biochemistry       Date:  2015-07-29       Impact factor: 3.162

Review 9.  New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Authors:  Esther Oder; Martin K Safo; Osheiza Abdulmalik; Gregory J Kato
Journal:  Br J Haematol       Date:  2016-09-08       Impact factor: 6.998

Review 10.  Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease.

Authors:  William A Eaton
Journal:  Mol Aspects Med       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.